Uniphar Past Earnings Performance
Past criteria checks 2/6
Uniphar has been growing earnings at an average annual rate of 23.4%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 9.8% per year. Uniphar's return on equity is 13.5%, and it has net margins of 1.8%.
Key information
23.4%
Earnings growth rate
11.2%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 9.8% |
| Return on equity | 13.5% |
| Net Margin | 1.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Uniphar makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2,553 | 45 | 313 | 0 |
| 30 Sep 23 | 2,436 | 45 | 294 | 0 |
| 30 Jun 23 | 2,318 | 45 | 276 | 0 |
| 31 Mar 23 | 2,195 | 45 | 257 | 0 |
| 31 Dec 22 | 2,071 | 46 | 237 | 0 |
| 30 Sep 22 | 2,020 | 47 | 232 | 0 |
| 30 Jun 22 | 1,970 | 49 | 226 | 0 |
| 31 Mar 22 | 1,957 | 48 | 222 | 0 |
| 31 Dec 21 | 1,943 | 48 | 217 | 0 |
| 30 Sep 21 | 1,930 | 39 | 206 | 0 |
| 30 Jun 21 | 1,917 | 30 | 195 | 0 |
| 31 Mar 21 | 1,871 | 29 | 183 | 0 |
| 31 Dec 20 | 1,824 | 28 | 171 | 0 |
| 30 Sep 20 | 1,780 | 26 | 164 | 0 |
| 30 Jun 20 | 1,736 | 25 | 158 | 0 |
| 31 Mar 20 | 1,701 | 23 | 149 | 0 |
| 31 Dec 19 | 1,665 | 21 | 141 | 0 |
| 30 Sep 19 | 1,607 | 20 | 130 | 0 |
| 30 Jun 19 | 1,549 | 19 | 119 | 0 |
| 31 Mar 19 | 1,484 | 14 | 105 | 0 |
| 31 Dec 18 | 1,418 | 9 | 92 | 0 |
| 31 Dec 17 | 1,265 | -2 | 83 | 0 |
| 31 Dec 16 | 1,294 | 5 | 79 | 0 |
| 31 Dec 15 | 1,117 | 6 | 60 | 0 |
| 31 Dec 14 | 1,129 | -19 | 68 | 0 |
| 31 Dec 13 | 860 | -18 | 39 | 0 |
Quality Earnings: UPR has high quality earnings.
Growing Profit Margin: UPR's current net profit margins (1.8%) are lower than last year (2.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: UPR's earnings have grown significantly by 23.4% per year over the past 5 years.
Accelerating Growth: UPR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: UPR had negative earnings growth (-1.7%) over the past year, making it difficult to compare to the Healthcare industry average (2%).
Return on Equity
High ROE: UPR's Return on Equity (13.5%) is considered low.